Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
- Autores
- Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; Robbio, Juan; Serpa, Marianna S.; Branco, Gabriela P.; Santos, Luana B. C.; Claro, Laura C. L.; Oliveira dos Santos, Gabriel; Kupper, Bruna E. C.; da Silva, Israel T.; Llera, Andrea Sabina; de Mello, Celso A. L.; Riechelmann, Rachel P.; Dias Neto, Emmanuel; Iseas, Soledad; Aguiar, Samuel; Nunes, Diana Noronha
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies.
Fil: Takenaka, Isabella Kuniko T. M.. No especifíca;
Fil: Bartelli, Thais F.. No especifíca;
Fil: Defelicibus, Alexandre. No especifíca;
Fil: Sendoya, Juan Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: Golubicki, Mariano. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina
Fil: Robbio, Juan. No especifíca;
Fil: Serpa, Marianna S.. No especifíca;
Fil: Branco, Gabriela P.. No especifíca;
Fil: Santos, Luana B. C.. No especifíca;
Fil: Claro, Laura C. L.. No especifíca;
Fil: Oliveira dos Santos, Gabriel. No especifíca;
Fil: Kupper, Bruna E. C.. No especifíca;
Fil: da Silva, Israel T.. No especifíca;
Fil: Llera, Andrea Sabina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina
Fil: de Mello, Celso A. L.. No especifíca;
Fil: Riechelmann, Rachel P.. No especifíca;
Fil: Dias Neto, Emmanuel. Universidade de Sao Paulo; Brasil
Fil: Iseas, Soledad. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina
Fil: Aguiar, Samuel. No especifíca;
Fil: Nunes, Diana Noronha. No especifíca; - Materia
-
BIOMARKERS OF TREATMENT RESPONSE
LOCALLY ADVANCED RECTAL CANCER
MICROBIOTA
MUTATIONAL SIGNATURES
NEOADJUVANT CHEMORADIOTHERAPY
WHOLE EXOME SEQUENCING - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/214903
Ver los metadatos del registro completo
id |
CONICETDig_3127f8b9e9c7ac714249387a463135b7 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/214903 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal CancerTakenaka, Isabella Kuniko T. M.Bartelli, Thais F.Defelicibus, AlexandreSendoya, Juan MartínGolubicki, MarianoRobbio, JuanSerpa, Marianna S.Branco, Gabriela P.Santos, Luana B. C.Claro, Laura C. L.Oliveira dos Santos, GabrielKupper, Bruna E. C.da Silva, Israel T.Llera, Andrea Sabinade Mello, Celso A. L.Riechelmann, Rachel P.Dias Neto, EmmanuelIseas, SoledadAguiar, SamuelNunes, Diana NoronhaBIOMARKERS OF TREATMENT RESPONSELOCALLY ADVANCED RECTAL CANCERMICROBIOTAMUTATIONAL SIGNATURESNEOADJUVANT CHEMORADIOTHERAPYWHOLE EXOME SEQUENCINGhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies.Fil: Takenaka, Isabella Kuniko T. M.. No especifíca;Fil: Bartelli, Thais F.. No especifíca;Fil: Defelicibus, Alexandre. No especifíca;Fil: Sendoya, Juan Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: Golubicki, Mariano. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; ArgentinaFil: Robbio, Juan. No especifíca;Fil: Serpa, Marianna S.. No especifíca;Fil: Branco, Gabriela P.. No especifíca;Fil: Santos, Luana B. C.. No especifíca;Fil: Claro, Laura C. L.. No especifíca;Fil: Oliveira dos Santos, Gabriel. No especifíca;Fil: Kupper, Bruna E. C.. No especifíca;Fil: da Silva, Israel T.. No especifíca;Fil: Llera, Andrea Sabina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; ArgentinaFil: de Mello, Celso A. L.. No especifíca;Fil: Riechelmann, Rachel P.. No especifíca;Fil: Dias Neto, Emmanuel. Universidade de Sao Paulo; BrasilFil: Iseas, Soledad. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; ArgentinaFil: Aguiar, Samuel. No especifíca;Fil: Nunes, Diana Noronha. No especifíca;Frontiers Media2022-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/214903Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; et al.; Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer; Frontiers Media; Frontiers in Oncology; 12; 3-2022; 1-162234-943XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.809441info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:58:18Zoai:ri.conicet.gov.ar:11336/214903instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:58:19.178CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer |
title |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer |
spellingShingle |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Takenaka, Isabella Kuniko T. M. BIOMARKERS OF TREATMENT RESPONSE LOCALLY ADVANCED RECTAL CANCER MICROBIOTA MUTATIONAL SIGNATURES NEOADJUVANT CHEMORADIOTHERAPY WHOLE EXOME SEQUENCING |
title_short |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer |
title_full |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer |
title_fullStr |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer |
title_full_unstemmed |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer |
title_sort |
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer |
dc.creator.none.fl_str_mv |
Takenaka, Isabella Kuniko T. M. Bartelli, Thais F. Defelicibus, Alexandre Sendoya, Juan Martín Golubicki, Mariano Robbio, Juan Serpa, Marianna S. Branco, Gabriela P. Santos, Luana B. C. Claro, Laura C. L. Oliveira dos Santos, Gabriel Kupper, Bruna E. C. da Silva, Israel T. Llera, Andrea Sabina de Mello, Celso A. L. Riechelmann, Rachel P. Dias Neto, Emmanuel Iseas, Soledad Aguiar, Samuel Nunes, Diana Noronha |
author |
Takenaka, Isabella Kuniko T. M. |
author_facet |
Takenaka, Isabella Kuniko T. M. Bartelli, Thais F. Defelicibus, Alexandre Sendoya, Juan Martín Golubicki, Mariano Robbio, Juan Serpa, Marianna S. Branco, Gabriela P. Santos, Luana B. C. Claro, Laura C. L. Oliveira dos Santos, Gabriel Kupper, Bruna E. C. da Silva, Israel T. Llera, Andrea Sabina de Mello, Celso A. L. Riechelmann, Rachel P. Dias Neto, Emmanuel Iseas, Soledad Aguiar, Samuel Nunes, Diana Noronha |
author_role |
author |
author2 |
Bartelli, Thais F. Defelicibus, Alexandre Sendoya, Juan Martín Golubicki, Mariano Robbio, Juan Serpa, Marianna S. Branco, Gabriela P. Santos, Luana B. C. Claro, Laura C. L. Oliveira dos Santos, Gabriel Kupper, Bruna E. C. da Silva, Israel T. Llera, Andrea Sabina de Mello, Celso A. L. Riechelmann, Rachel P. Dias Neto, Emmanuel Iseas, Soledad Aguiar, Samuel Nunes, Diana Noronha |
author2_role |
author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
BIOMARKERS OF TREATMENT RESPONSE LOCALLY ADVANCED RECTAL CANCER MICROBIOTA MUTATIONAL SIGNATURES NEOADJUVANT CHEMORADIOTHERAPY WHOLE EXOME SEQUENCING |
topic |
BIOMARKERS OF TREATMENT RESPONSE LOCALLY ADVANCED RECTAL CANCER MICROBIOTA MUTATIONAL SIGNATURES NEOADJUVANT CHEMORADIOTHERAPY WHOLE EXOME SEQUENCING |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies. Fil: Takenaka, Isabella Kuniko T. M.. No especifíca; Fil: Bartelli, Thais F.. No especifíca; Fil: Defelicibus, Alexandre. No especifíca; Fil: Sendoya, Juan Martín. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina Fil: Golubicki, Mariano. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina Fil: Robbio, Juan. No especifíca; Fil: Serpa, Marianna S.. No especifíca; Fil: Branco, Gabriela P.. No especifíca; Fil: Santos, Luana B. C.. No especifíca; Fil: Claro, Laura C. L.. No especifíca; Fil: Oliveira dos Santos, Gabriel. No especifíca; Fil: Kupper, Bruna E. C.. No especifíca; Fil: da Silva, Israel T.. No especifíca; Fil: Llera, Andrea Sabina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquímicas de Buenos Aires. Fundación Instituto Leloir. Instituto de Investigaciones Bioquímicas de Buenos Aires; Argentina Fil: de Mello, Celso A. L.. No especifíca; Fil: Riechelmann, Rachel P.. No especifíca; Fil: Dias Neto, Emmanuel. Universidade de Sao Paulo; Brasil Fil: Iseas, Soledad. Gobierno de la Ciudad de Buenos Aires. Hospital de Gastroenterología "Dr. Carlos B. Udaondo"; Argentina Fil: Aguiar, Samuel. No especifíca; Fil: Nunes, Diana Noronha. No especifíca; |
description |
The clinical and pathological responses to multimodal neoadjuvant therapy in locally advanced rectal cancers (LARCs) remain unpredictable, and robust biomarkers are still lacking. Recent studies have shown that tumors present somatic molecular alterations related to better treatment response, and it is also clear that tumor-associated bacteria are modulators of chemotherapy and immunotherapy efficacy, therefore having implications for long-term survivorship and a good potential as the biomarkers of outcome. Here, we performed whole exome sequencing and 16S ribosomal RNA (rRNA) amplicon sequencing from 44 pre-treatment LARC biopsies from Argentinian and Brazilian patients, treated with neoadjuvant chemoradiotherapy or total neoadjuvant treatment, searching for predictive biomarkers of response (responders, n = 17; non-responders, n = 27). In general, the somatic landscape of LARC was not capable to predict a response; however, a significant enrichment in mutational signature SBS5 was observed in non-responders (p = 0.0021), as well as the co-occurrence of APC and FAT4 mutations (p < 0.05). Microbiota studies revealed a similar alpha and beta diversity of bacteria between response groups. Yet, the linear discriminant analysis (LDA) of effect size indicated an enrichment of Hungatella, Flavonifractor, and Methanosphaera (LDA score ≥3) in the pre-treatment biopsies of responders, while non-responders had a higher abundance of Enhydrobacter, Paraprevotella (LDA score ≥3) and Finegoldia (LDA score ≥4). Altogether, the evaluation of these biomarkers in pre-treatment biopsies could eventually predict a neoadjuvant treatment response, while in post-treatment samples, it could help in guiding non-operative treatment strategies. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/214903 Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; et al.; Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer; Frontiers Media; Frontiers in Oncology; 12; 3-2022; 1-16 2234-943X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/214903 |
identifier_str_mv |
Takenaka, Isabella Kuniko T. M.; Bartelli, Thais F.; Defelicibus, Alexandre; Sendoya, Juan Martín; Golubicki, Mariano; et al.; Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer; Frontiers Media; Frontiers in Oncology; 12; 3-2022; 1-16 2234-943X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.3389/fonc.2022.809441 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Frontiers Media |
publisher.none.fl_str_mv |
Frontiers Media |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269514883923968 |
score |
13.13397 |